Tag: home delivery investigational products

Direct-to-Patient Logistics in Clinical Trials: Compliance and Oversight

Posted on digi By digi

Direct-to-Patient Logistics in Clinical Trials: Compliance and Oversight Direct-to-Patient Clinical Trial Logistics: Ensuring Compliance and Patient Safety Introduction: The Rise of Direct-to-Patient (DTP) Logistics Direct-to-Patient (DTP) logistics represents a paradigm shift in clinical trial supply chains. Instead of relying solely on investigational sites, IMPs (Investigational Medicinal Products) are delivered directly to participants’ homes. This model…

Read More “Direct-to-Patient Logistics in Clinical Trials: Compliance and Oversight” »

Clinical Trial Logistics, Clinical Trial Operations & Compliance

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience

Posted on digi By digi

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience Bringing Clinical Trials Home: Direct-to-Patient Drug Delivery for Modern Research Direct-to-Patient (DTP) drug delivery has become a pivotal innovation in decentralized and hybrid clinical trials, enabling investigational products (IP) to reach participants directly at their homes. By minimizing site visits and enhancing patient convenience, DTP…

Read More “Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience” »

Decentralized Clinical Trials (DCTs), Direct-to-Patient Drug Delivery